Filter Results:
(1,246)
Show Results For
- All HBS Web
(1,246)
- People (5)
- News (171)
- Research (929)
- Events (6)
- Multimedia (12)
- Faculty Publications (758)
Show Results For
- All HBS Web
(1,246)
- People (5)
- News (171)
- Research (929)
- Events (6)
- Multimedia (12)
- Faculty Publications (758)
- April 1990 (Revised November 1992)
- Case
Population Services International: The Social Marketing Project in Bangladesh (Abridged)
By: James E. Austin
Population Services International (PSI) was a not-for-profit agency founded to disseminate family planning information and to market birth control products, primarily in less developed countries seeking to curb their population explosions. In 1976, PSI concluded an... View Details
Keywords: Conferences; Developing Countries and Economies; Information Publishing; Growth and Development Strategy; Marketing Strategy; Social Marketing; Agreements and Arrangements; Product; Nonprofit Organizations; Pharmaceutical Industry; Bangladesh; Washington (state, US)
Austin, James E. "Population Services International: The Social Marketing Project in Bangladesh (Abridged)." Harvard Business School Case 590-061, April 1990. (Revised November 1992.)
- April 1978
- Case
FTC and Listerine Antiseptic
Keywords: Business and Government Relations; Misleading and Fraudulent Advertising; Pharmaceutical Industry
Greyser, Stephen A. "FTC and Listerine Antiseptic." Harvard Business School Case 578-166, April 1978.
- February 1973 (Revised June 1973)
- Case
Listerine Antiseptic (A)
Greyser, Stephen A. "Listerine Antiseptic (A)." Harvard Business School Case 573-060, February 1973. (Revised June 1973.)
- September 1990 (Revised November 1991)
- Supplement
Merck & Co., Inc. (C)
Discusses the 1989 modified performance appraisal program by adding performance gradations and allowing for differences in employee rating distributions depending on the division performance for the year. The objective is to have students discuss the revisions in the... View Details
Murphy, Kevin J. "Merck & Co., Inc. (C)." Harvard Business School Supplement 491-007, September 1990. (Revised November 1991.)
- March 1999 (Revised January 2001)
- Case
Hans Fritz at Novartis Thailand (B): The First Six Months
By: Michael Y. Yoshino and Carin-Isabel Knoop
Supplements the (A) case. View Details
Yoshino, Michael Y., and Carin-Isabel Knoop. "Hans Fritz at Novartis Thailand (B): The First Six Months." Harvard Business School Case 399-124, March 1999. (Revised January 2001.)
- November 1978 (Revised January 1983)
- Case
Vick International Division: Tom McGuire
Explores the ways in which International Division management uses formal management systems in carrying out its roles in the management processes of one division of a diversified drug company. View Details
Keywords: Globalized Firms and Management; Business Divisions; Management Systems; Pharmaceutical Industry
Vancil, Richard F. "Vick International Division: Tom McGuire." Harvard Business School Case 179-068, November 1978. (Revised January 1983.)
- August 1989 (Revised October 2005)
- Case
James Burke: A Career in American Business (B)
By: Richard S. Tedlow and Wendy Smith
Covers the history of Tylenol from the autumn of 1982 through the second tampering incident in February 1986. Also deals with other developments in the history of Johnson & Johnson, especially the acquisition and divestiture of Technicare. View Details
Tedlow, Richard S., and Wendy Smith. "James Burke: A Career in American Business (B)." Harvard Business School Case 390-030, August 1989. (Revised October 2005.)
- 23 Mar 2010
- First Look
First Look: March 23
catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of side effects, with the... View Details
Keywords: Martha Lagace
- 01 Dec 2003
- News
The Next Big Thing
life-sciences center of the world, by virtue of its unsurpassed “cluster” of world-renowned universities and teaching hospitals; medical-device, biotech, and pharmaceutical companies; financial firms; and skilled workers. “The leadership... View Details
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International, a struggling U.S. View Details
Keywords: Garry Emmons
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 01 Mar 2012
- News
How to Close the Health Gap
real progress has been made over the last decade, thanks in part to funding from organizations such as the Bill & Melinda Gates Foundation and efforts by pharmaceutical companies and governments to make drugs available at little or no... View Details
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid... View Details
Keywords: by Wendy Guild
- 26 Jul 2016
- Working Paper Summaries
The Impact of the Entry of Biosimilars: Evidence from Europe
- 01 Sep 2012
- News
A Silent Workplace Crisis
pharmaceuticals, the gap between the medical and the mental health systems, and the time required to find community resources and quality home care. My previous experience as a pharmaceutical executive and management consultant seemed... View Details
- 01 Jun 2000
- News
The Right Connections
prospectuses of all public biotech firms going back twenty years. Information from 295 companies and more than 3,000 executives formed the core of their study. The results showed that top managers' ties to notable pharmaceutical companies... View Details
Keywords: Judith A. Ross
- 01 Mar 2005
- News
Facing Ambiguity
successfully executed in a paper case.” The case, which will be taught this spring in the MBA second-year course General Management: Processes and Action, debuted last fall in a customized Executive Education program for a group of View Details
- 26 Apr 2004
- Research & Ideas
A Clear Eye for Innovation
is Ciba Vision. Established in the early 1980s as a unit of the Swiss pharmaceutical giant Ciba-Geigy (now Novartis), the Atlanta-based Ciba Vision sells contact lenses and related eye-care products to optometrists and consumers. Although... View Details
- 01 Dec 2013
- News
Your Own Medicine
help build new muscle—had been one of several potential treatments the Secklers chased to no avail, often stuck following promising science to dead ends. That changed three years ago, when former pharmaceutical executive Gene Williams... View Details
- Profile
Paul Wang
work with the MIT’s Abdul Latif Jameel Poverty Action Lab (J-PAL). “They’re a group of economists who use randomized evaluation methodologies, similar to those used in pharmaceutical trials, to assess the impact of development projects,”... View Details